MetaVia Inc. (MTVA): Cash & Equivalents
$10.28M
As of 2025-12-31
$12.63M
As of 2026-06-30
-32.5%
3-year compound annual growth
+0.4%
5-year compound annual growth
+11.0%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.28M | -35.8% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $16.02M | -28.6% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $22.43M | -32.8% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $33.36M | +103.6% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $16.39M | +62.4% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $10.09M | -27.5% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $13.91M | +388.9% | 2021-04-15, Balance as of period end |
| 2018-12-31 | $2.85M | -84.6% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $18.47M | -23.1% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $24.03M | +563.9% | 2019-03-18, Balance as of period end |
| 2015-12-31 | $3.62M | n/m | 2018-03-20, Balance as of period end |
| 2014-12-31 | $317.0K | n/a | 2017-03-21, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| MetaVia Inc. (MTVA) | 2025-12-31 | $10.28M | -35.8% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $6.35M | +124.0% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $10.71M | +339.9% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.42M | -41.1% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $2.20M | +238.6% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $5.00M | n/a |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $10.70M | +64.6% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $334.0K | -82.6% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $3.12M | -26.7% |
Compare MTVA, MIRA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗